KARLSSON-TUNER INVEST AS (KTIAS)

VAT Number: 998 076 935

Founded: December 2, 2011

KTIAS has invested in a medical project dealing with treatment of chronic neuropathy caused by platinum-containing chemotherapeutics. The method used to treat neuropathy is covered by patents granted in USA, Europe, China and Japan. The company is seeking a partner to develop this project into an approved drug.